|
Volumn 4, Issue 4, 2006, Pages 279-289
|
Cost-effectiveness of impedance cardiography testing in uncontrolled hypertension.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG EFFECT;
ECONOMICS;
FEMALE;
FOLLOW UP;
HUMAN;
HYPERTENSION;
IMPEDANCE CARDIOGRAPHY;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
QUALITY ADJUSTED LIFE YEAR;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
RISK REDUCTION;
SENSITIVITY AND SPECIFICITY;
TIME;
TREATMENT OUTCOME;
UNITED STATES;
ADOLESCENT;
ADULT;
AGED;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CARDIOGRAPHY, IMPEDANCE;
COST-BENEFIT ANALYSIS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
QUALITY-ADJUSTED LIFE YEARS;
RISK FACTORS;
RISK REDUCTION BEHAVIOR;
SENSITIVITY AND SPECIFICITY;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 39049195832
PISSN: 15419215
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1541-9215.2006.05728.x Document Type: Article |
Times cited : (9)
|
References (0)
|